As of 2024-12-13, the EV/EBITDA ratio of PRA Health Sciences Inc (PRAH) is
25.94.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRAH's latest enterprise value
is 11,283.55 mil USD. PRAH's TTM EBITDA according to its financial statements is
435.00 mil USD. Dividing these 2
quantities gives us the above PRAH EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
12.2x - 13.2x |
12.3x |
| Forward P/E multiples |
13.8x - 15.5x |
14.4x |
| Fair Price |
72.70 - 96.25 |
81.26 |
| Upside |
-56.0% - -41.7% |
-50.8% |